Primary |
Product Used For Unknown Indication |
21.5% |
Contraception |
19.7% |
Acne |
12.0% |
Drug Use For Unknown Indication |
11.3% |
Premenstrual Syndrome |
8.9% |
Oral Contraception |
4.2% |
Pain |
4.0% |
Depression |
2.3% |
Menstruation Irregular |
2.0% |
Anxiety |
1.9% |
Migraine |
1.7% |
Menstrual Cycle Management |
1.6% |
Asthma |
1.4% |
Headache |
1.3% |
Dysmenorrhoea |
1.2% |
Menorrhagia |
1.2% |
Gastrooesophageal Reflux Disease |
1.0% |
Polycystic Ovaries |
1.0% |
Multiple Allergies |
1.0% |
Hypertension |
0.9% |
|
Pain |
18.2% |
Pulmonary Embolism |
16.2% |
Injury |
10.6% |
Deep Vein Thrombosis |
7.4% |
Gallbladder Disorder |
5.6% |
Cholecystectomy |
4.5% |
Thrombosis |
3.9% |
Anxiety |
3.7% |
Emotional Distress |
3.6% |
Gallbladder Injury |
3.6% |
Cholelithiasis |
3.4% |
Cholecystitis Chronic |
3.3% |
Vomiting |
3.1% |
Metrorrhagia |
2.7% |
Nausea |
2.0% |
No Adverse Event |
2.0% |
Cerebrovascular Accident |
1.9% |
Vaginal Haemorrhage |
1.7% |
General Physical Health Deterioration |
1.4% |
Abdominal Pain |
1.3% |
|
Secondary |
Contraception |
21.8% |
Premenstrual Syndrome |
18.2% |
Acne |
14.6% |
Product Used For Unknown Indication |
9.1% |
Oral Contraception |
4.3% |
Pain |
3.7% |
Menstruation Irregular |
3.7% |
Menstrual Cycle Management |
2.9% |
Depression |
2.7% |
Dysmenorrhoea |
2.4% |
Migraine |
2.3% |
Anxiety |
2.1% |
Polycystic Ovaries |
2.1% |
Menorrhagia |
2.0% |
Drug Use For Unknown Indication |
1.7% |
Asthma |
1.7% |
Headache |
1.3% |
Gastrooesophageal Reflux Disease |
1.2% |
Multiple Allergies |
1.2% |
Hypertension |
1.0% |
|
Pain |
17.5% |
Pulmonary Embolism |
13.4% |
Injury |
8.5% |
Deep Vein Thrombosis |
7.5% |
Cholecystitis Chronic |
6.7% |
Gallbladder Disorder |
6.1% |
Cholelithiasis |
4.9% |
Anxiety |
4.7% |
Vomiting |
4.5% |
Emotional Distress |
4.2% |
Gallbladder Injury |
3.4% |
Thrombosis |
2.8% |
Nausea |
2.6% |
Abdominal Pain |
2.2% |
Cholecystectomy |
2.1% |
Abdominal Pain Upper |
2.1% |
Cholecystitis |
2.0% |
Depression |
1.6% |
Chest Pain |
1.6% |
Dyspnoea |
1.5% |
|
Concomitant |
Contraception |
22.1% |
Product Used For Unknown Indication |
13.0% |
Drug Use For Unknown Indication |
10.9% |
Crohn's Disease |
6.6% |
Depression |
5.4% |
Asthma |
5.2% |
Rheumatoid Arthritis |
5.2% |
Acne |
4.3% |
Multiple Sclerosis |
3.3% |
Pain |
3.3% |
Anxiety |
2.5% |
Post Coital Contraception |
2.4% |
Oral Contraception |
2.4% |
Bipolar Disorder |
2.1% |
Diffuse Large B-cell Lymphoma |
2.1% |
Hypersensitivity |
2.0% |
Menstrual Cycle Management |
1.9% |
Abdominal Pain |
1.8% |
Migraine |
1.7% |
Gastrooesophageal Reflux Disease |
1.7% |
|
Unintended Pregnancy |
14.1% |
Pregnancy |
11.5% |
Menstruation Irregular |
9.0% |
Weight Increased |
7.3% |
Headache |
6.0% |
Nausea |
6.0% |
Vomiting |
6.0% |
Urticaria |
4.7% |
Injection Site Pain |
3.8% |
Rash |
3.8% |
Off Label Use |
3.4% |
Vaginal Haemorrhage |
3.4% |
Somnolence |
3.0% |
Fatigue |
2.6% |
Metrorrhagia |
2.6% |
Pruritus |
2.6% |
Small Intestinal Obstruction |
2.6% |
Tremor |
2.6% |
Weight Decreased |
2.6% |
Wrong Technique In Drug Usage Process |
2.6% |
|
Interacting |
Contraception |
43.8% |
Product Used For Unknown Indication |
43.8% |
Acne |
6.3% |
Convulsion |
6.3% |
|
Pneumonia |
50.0% |
Acne |
25.0% |
Irritability |
25.0% |
|